Literature DB >> 3132296

Treatment of hypercalcaemia of malignancy.

S H Ralston, I T Boyle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3132296      PMCID： PMC2545916          DOI： 10.1136/bmj.296.6634.1468-b

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  An investigation into the mechanism of citrate-Fe2+-dependent lipid peroxidation.

Authors:  G Minotti; S D Aust
Journal:  Free Radic Biol Med       Date:  1987       Impact factor: 7.376

2.  Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer.

Authors:  B M Cantwell; A L Harris
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

3.  A single-day treatment of tumor-induced hypercalcemia by intravenous amino-hydroxypropylidene bisphosphonate.

Authors:  D Thiébaud; P Jaeger; A F Jacquet; P Burckhardt
Journal:  J Bone Miner Res       Date:  1986-12       Impact factor: 6.741

4.  A comparison of single and multiple intravenous infusions of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD) in the treatment of hypercalcemia of malignancy.

Authors:  A J Yates; R M Murray; G J Jerums; T J Martin
Journal:  Aust N Z J Med       Date:  1987-08

5.  3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.

Authors:  R E Coleman; R D Rubens
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.